DELL'OSTE, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 137
AS - Asia 118
NA - Nord America 96
Totale 351
Nazione #
US - Stati Uniti d'America 93
HK - Hong Kong 60
SG - Singapore 48
IT - Italia 44
IE - Irlanda 28
DE - Germania 16
BE - Belgio 12
CN - Cina 10
SE - Svezia 7
UA - Ucraina 7
FR - Francia 6
GB - Regno Unito 6
LT - Lituania 6
CA - Canada 3
ES - Italia 2
FI - Finlandia 2
RO - Romania 1
Totale 351
Città #
Hong Kong 55
Singapore 43
Dublin 28
Dearborn 14
Jacksonville 13
Antwerp 8
Turin 8
Chandler 7
Naples 7
Frankfurt am Main 5
Brussels 4
Munich 4
Aosta 3
Boardman 3
Lawrence 3
Orpington 3
Princeton 3
Rome 3
San Mateo 3
Santa Clara 3
Toronto 3
Ann Arbor 2
Ashburn 2
Beijing 2
Florence 2
Fort Worth 2
Helsinki 2
Iesi 2
Kunming 2
Milan 2
Prato 2
Springfield 2
Wilmington 2
Alcanar 1
Bilbao 1
Brescia 1
Hefei 1
Horia 1
Jinan 1
London 1
Palermo 1
Piemonte 1
Prineville 1
San Diego 1
Shanghai 1
Wenzhou 1
Yinchuan 1
Totale 261
Nome #
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 71
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS 68
Defective fas function and variation of perforin gene in a patient with epidermodysplasia verruciformis 32
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 21
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 12
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 10
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 9
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease 9
50° Congresso Nazionale della Società Italiana di Microbiologia 9
Antimicrobial Efficacy of a Vegetable Oil Plasticizer in PVC Matrices 9
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 8
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 8
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 8
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 8
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 7
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 7
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 7
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 7
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 7
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 7
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 7
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 7
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 7
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 6
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 6
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 6
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 5
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 5
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 5
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 3
Totale 381
Categoria #
all - tutte 2.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 8 3 3 1 2 0
2020/202123 2 0 3 1 2 2 6 1 3 0 3 0
2021/202217 0 0 4 2 0 0 0 0 3 0 1 7
2022/202356 3 0 7 0 2 2 1 6 31 0 2 2
2023/202422 2 2 4 0 5 0 2 0 0 0 5 2
2024/2025220 0 42 62 10 43 56 7 0 0 0 0 0
Totale 381